Centers for Medicare & Medicaid Services (CMS) recently released its List of Measures under Consideration.
One of the measures under consideration is MUC17-210 which measures “Hospital Harm Performance Measure: Opioid Related Adverse Respiratory Events”:
“This measure will assess opioid related adverse respiratory events (ORARE) in the hospital setting. The goal for this measure is to assess the rate at which naloxone is given for opioid related adverse respiratory events that occur in the hospital setting, using a valid method that reliably allows comparison across hospitals.”
We would like to thank all of those who submitted comments on the proposed quality measure being considered by CMS regarding the monitoring of patients using patient-controlled analgesia (PCA) pumps.
In the report submitted by the National Quality Forum to the United States Department of Health and Human Services, the measure was not endorsed and it was decided that the measure “requires modification or further development”. More particularly, the report provides: Read More
by Michael Wong
(This article is reprinted with the permission of Patient Safety & Quality Healthcare (PSQH).)
This is the question that I have been asking myself ever since Centers for Medicare & Medicaid Services (CMS) recently announced proposed quality measures it is considering for adoption through rule making for the Medicare program. Read More